Miransertib, CAS [[1313881-70-7]]

Produktübersicht

• Artikelname: Miransertib, CAS [[1313881-70-7]]
• Artikelnummer: MCE-HY-19719
• Hersteller Artikelnummer: HY-19719
• Alternativnummer: MCE-HY-19719-10MG,MCE-HY-19719-50MG,MCE-HY-19719-10MMX1ML,MCE-HY-19719-25MG,MCE-HY-19719-5MG,MCE-HY-19719-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: ARQ-092

Produktbeschreibung

Miransertib (ARQ-092) is a potent, orally active, selective and allosteric Akt inhibitor with IC50s of 2.7 nM, 14 nM and 8.1 nM for Akt1, Akt2, Akt3, respectively. Miransertib is also a potent the AKT1-E17K mutant protein inhibitor and has the potential for PI3K/AKT-driven tumors and Proteus syndrome research[1]. Miransertib is effective against Leishmania[2].

Produkteigenschaften

• Molekulargewicht: 432.52
• Reinheit: 99.32
• CAS Nummer: [1313881-70-7]
• Formel: C27H24N6
• Target-Kategorie: Akt,Parasite

Anwendungsbeschreibung

• Anwendungsbeschreibung: Reference compound